87 related articles for article (PubMed ID: 8394483)
1. Serum interleukin-2 receptor levels in Hodgkin disease and other solid tumors of childhood.
Pui CH; Hudson M; Luo X; Wilimas J; Evans W; Crist WM
Leukemia; 1993 Aug; 7(8):1242-4. PubMed ID: 8394483
[TBL] [Abstract][Full Text] [Related]
2. High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease.
Pui CH; Ip SH; Thompson E; Wilimas J; Brown M; Dodge RK; de Hoyos RA; Berard CW; Crist WM
Leukemia; 1989 Jul; 3(7):481-4. PubMed ID: 2786597
[TBL] [Abstract][Full Text] [Related]
3. Serum intercellular adhesion molecule-1 in childhood malignancy.
Pui CH; Luo X; Evans W; Martin S; Rugg A; Wilimas J; Crist WM; Hudson M
Blood; 1993 Aug; 82(3):895-8. PubMed ID: 8101731
[TBL] [Abstract][Full Text] [Related]
4. Incidence of anemia in children with solid tumors or Hodgkin disease.
Hockenberry MJ; Hinds PS; Barrera P; Billups C; Rodriguez-Galindo C; Tan M; Kline N; Razzouk B
J Pediatr Hematol Oncol; 2002 Jan; 24(1):35-7. PubMed ID: 11902737
[TBL] [Abstract][Full Text] [Related]
5. Visual presentation of the staging of pediatric solid tumors.
Cohen MD; Bugaieski EM; Haliloglu M; Faught P; Siddiqui AR
Radiographics; 1996 May; 16(3):523-45. PubMed ID: 8897621
[TBL] [Abstract][Full Text] [Related]
6. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.
Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
Leukemia; 1993 Aug; 7(8):1245-9. PubMed ID: 8102418
[TBL] [Abstract][Full Text] [Related]
8. [Serum ferritin as a possible tumor marker in malignant tumors of children].
Balitskaia OV; Chebotareva ED
Pediatriia; 1987; (2):64-7. PubMed ID: 3033595
[No Abstract] [Full Text] [Related]
9. Is the NBN gene mutation I171V a potential risk factor for malignant solid tumors in children?
Nowak J; Mosor M; Nowicka K; Rembowska J; Januszkiewicz D
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e248-9. PubMed ID: 21436738
[TBL] [Abstract][Full Text] [Related]
10. Selenium concentration and glutathione peroxidase activity in blood of children with cancer.
Wasowicz W; Gromadzińska J; Skłodowska M; Popadiuk S
J Trace Elem Electrolytes Health Dis; 1994 Mar; 8(1):53-7. PubMed ID: 7804031
[TBL] [Abstract][Full Text] [Related]
11. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in cancer. Solid tumors in children.
Maurer HM
N Engl J Med; 1978 Dec; 299(24):1345-8. PubMed ID: 213716
[No Abstract] [Full Text] [Related]
13. [Serum copper level in children with malignant neoplasms].
Czernik J; Sawicz-Birkowska K; Wronecki K; Andrzejak R
Wiad Lek; 1987 Feb; 40(4):221-5. PubMed ID: 3039742
[No Abstract] [Full Text] [Related]
14. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.
Wieland A; Kerbl R; Berghold A; Schwinger W; Mann G; Urban C
Med Pediatr Oncol; 2003 Jul; 41(1):21-5. PubMed ID: 12764738
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma.
Morito T; Fujihara M; Asaoku H; Tari A; Sato Y; Ichimura K; Tanaka T; Takata K; Tamura M; Yoshino T
Cancer Sci; 2009 Jul; 100(7):1255-60. PubMed ID: 19432905
[TBL] [Abstract][Full Text] [Related]
18. The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease.
Gruss HJ; Dölken G; Brach MA; Mertelsmann R; Herrmann F
Leukemia; 1993 Sep; 7(9):1339-43. PubMed ID: 8396696
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
[TBL] [Abstract][Full Text] [Related]
20. [Current problems of solid tumors in childhood].
Plüss HJ; Sartorius J; Wagner HP; Wyss M
Schweiz Med Wochenschr; 1974 May; 104(18):634-41. PubMed ID: 4363542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
